Filip Janku's most recent trade in Monte Rosa Therapeutics Inc was a trade of 161,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 2, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Monte Rosa Therapeutics Inc | Filip Janku | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 161,000 | 161,000 | - | - | Stock Option (Right to Buy) | |
Monte Rosa Therapeutics Inc | Filip Janku | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 36,000 | 45,189 | - | - | Common Stock | |
Monte Rosa Therapeutics Inc | Filip Janku | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Sep 2024 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
Monte Rosa Therapeutics Inc | Janku Filip | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 121,000 | 121,000 | - | - | Stock Option (Right to Buy) | |
Monte Rosa Therapeutics Inc | Filip Janku | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 135,000 | 135,000 | - | - | Stock Option (Right to Buy) | |
Monte Rosa Therapeutics Inc | Filip Janku | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2022 | 36,000 | 36,000 | - | - | Stock Option (Right to Buy) | |
Monte Rosa Therapeutics Inc | Filip Janku | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2022 | 36,000 | 36,000 | - | - | Stock Option (Right to Buy) | |
Monte Rosa Therapeutics Inc | Filip Janku | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 86,500 | 86,500 | - | - | Stock Option (Right to Buy) | |
Monte Rosa Therapeutics Inc | Filip Janku | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2021 | 387,069 | 387,069 | - | - | Stock Option (Right to Buy) |